Sialylation-dependent interaction between PD-L1 and CD169 promotes monocytes adhesion to endothelial cells

被引:5
|
作者
Cai, Kebo [1 ]
Chen, Qihang [2 ]
Shi, Danfang [2 ]
Huang, Sijing [2 ]
Wang, Cong [3 ,4 ,6 ]
Ai, Zhilong [4 ]
Jiang, Jianhai [2 ,5 ]
机构
[1] Shanghai Jiao Tong Univ, Xin Hua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China
[2] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, NHC Key Lab Glycoconjugates Res, Shanghai 200032, Peoples R China
[3] Fudan Zhangjiang Inst, Project management Ctr, Shanghai 201203, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200032, Peoples R China
[5] Fudan Univ, Sch Basic Med Sci, Shanghai 200032, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Fudan Zhangjiang Inst, Dept Gen Surg, Shanghai 200032, Peoples R China
关键词
adhesion; PD-L1; CD169; alpha; 2; 3-sialylation; interaction; IFN-GAMMA; TNF-ALPHA; INTERFERON-GAMMA; E-SELECTIN; VASCULAR ENDOTHELIUM; CANCER CELLS; P-SELECTIN; EXPRESSION; BINDING; ICAM-1;
D O I
10.1093/glycob/cwad005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The monocytes adhesion to endothelial cells is an early step in chronic inflammation. Interferon-gamma (IFN-gamma) is regarded as a master regulator of inflammation development. However, the significance and mechanisms of IFN-gamma in the monocyte adhesion to endothelial cells remains largely unknown. IFN-gamma up-regulates PD-L1 on various types of cells. Here, we performed flow cytometry to examine the contribution of IFN-gamma-induced PD-L1 expression on the monocytes adhesion to endothelial cells. Up-regulation of PD-L1 by IFN-gamma enhanced the adhesion of monocytes to endothelial cells. By immunoprecipitation and lectin blot, PD-L1 in endothelial cells interacted with CD169/Siglec 1 in monocyte depending on the alpha 2,3-sialylation of PD-L1. ST3Gal family (ST3 beta-galactoside alpha-2,3-sialyltransferase) was the major glycosyltransferase responsible for the alpha 2,3-sialylation of membranes proteins. Down-regulation of ST3Gal4 by RNAinterference partially reduced the alpha 2,3-sialylation of PD-L1 and the PD-L1-CD169 interaction. Finally, purified PD-L1 protein with alpha 2,3-sialylation, but not PD-L1 protein without alpha 2,3-sialylation, partially reduced IFN-gamma-induced monocytes adhesion to endothelial cells. These findings provide evidence that the interaction between PD-L1 and CD169 promoted monocytes adhesion to endothelial cells and might elucidate a new mechanism of monocytes adhesion to endothelial cells.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
  • [21] Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma
    Kim, Jeongsoo
    Kim, Tae-Jin
    Chae, Sehyun
    Ha, Hyojeong
    Park, Yejin
    Park, Sunghee
    Yoon, Chul Joo
    Lim, Seon Ah
    Lee, Hyemin
    Kim, Jiyoung
    Kim, Jungwon
    Im, Kyungtaek
    Lee, Kyunghye
    Kim, Jeongmin
    Kim, Daham
    Lee, Eunju
    Shin, Min Hwa
    Park, Serk In
    Rhee, Inmoo
    Jung, Keehoon
    Lee, Jeewon
    Lee, Keun Hwa
    Hwang, Daehee
    Lee, Kyung-Mi
    MOLECULAR CANCER, 2024, 23 (01)
  • [22] IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells
    Wei, Yuanyan
    Shi, Danfang
    Liang, Ziwei
    Liu, Yuming
    Li, Yinan
    Xing, Yang
    Liu, Weitao
    Ai, Zhilong
    Zhuang, Jianhui
    Chen, Xiaoning
    Gao, Qiang
    Jiang, Jianhai
    JOURNAL OF HEPATOLOGY, 2019, 71 (06) : 1206 - 1215
  • [23] PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma
    Wang, Xi-Peng
    Guo, Wei
    Chen, Ye-Fan
    Hong, Chen
    Ji, Juan
    Zhang, Xi-Yue
    Dong, Yin-Feng
    Sun, Xiu-Lan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [24] Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands
    Meier, Angela
    Bagchi, Aranya
    Sidhu, Harlyn K.
    Alter, Galit
    Suscovich, Todd J.
    Kavanagh, Daniel G.
    Streeck, Hendrik
    Brockman, Mark A.
    LeGall, Sylvie
    Heilman, Judith
    Altfeld, Marcus
    AIDS, 2008, 22 (05) : 655 - 658
  • [25] Sex-dependent PD-L1/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF
    Baggio, Chiara
    Ramaschi, Giovanni Eugenio
    Oliviero, Francesca
    Ramonda, Roberta
    Sfriso, Paolo
    Trevisi, Lucia
    Cignarella, Andrea
    Bolego, Chiara
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [26] Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells
    Shijia Wang
    Guan Wang
    Liying Zhang
    Fengying Li
    Keli Liu
    Ying Wang
    Yufang Shi
    Kai Cao
    Cell & Bioscience, 10
  • [27] Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells
    Wang, Shijia
    Wang, Guan
    Zhang, Liying
    Li, Fengying
    Liu, Keli
    Wang, Ying
    Shi, Yufang
    Cao, Kai
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [28] The effect of PD-1/PD-L1 signaling axis on the interaction between CD19+B cells and CD4+T cells in peripheral blood of patients with systemic lupus erythematosus
    Zhuobei Xie
    Li Dai
    Haohua He
    Dengxiao Hong
    Honghui Tang
    Wenyan Xu
    Zhongxin Chen
    Hongtao Wang
    Baiqing Li
    Changhao Xie
    Yuanyuan Wang
    Advances in Rheumatology, 63
  • [29] The effect of PD-1/PD-L1 signaling axis on the interaction between CD19+B cells and CD4+T cells in peripheral blood of patients with systemic lupus erythematosus
    Xie, Zhuobei
    Dai, Li
    He, Haohua
    Hong, Dengxiao
    Tang, Honghui
    Xu, Wenyan
    Chen, Zhongxin
    Wang, Hongtao
    Li, Baiqing
    Xie, Changhao
    Wang, Yuanyuan
    ADVANCES IN RHEUMATOLOGY, 2023, 63 (01)
  • [30] Differential Effects of Anti-PD-1/PD-L1 Checkpoint Inhibitors on Adhesion Molecules and Cytokine Secretion by THP-1 Monocytes
    Probst, Eva
    Franzen, Klaas F.
    Idel, Christian
    Ploetze-Martin, Kirstin
    Fleckner, Jonas
    Rades, Dirk
    Bohnet, Sabine
    Bruchhage, Karl-Ludwig
    Pries, Ralph
    ANTICANCER RESEARCH, 2023, 43 (06) : 2445 - 2454